Our Labcorp Cell & Gene Therapy team shared some of the advantages and challenges of cell & gene therapy, key differences between autologous and allogeneic cell therapies and how to overcome common hurdles to enable effective patient access, recruitment and retention to advance these novel therapeutics.

The cell and gene therapy landscape is experiencing a season of exponential growth within drug development. With more assets entering preclinical development every day, Labcorp underscores the importance of designing trials and strategies with the end goals in mind from the very beginning.

30% More Genetic Toxicology Space

Your continuing requirements to find new options for product testing inspired us to grow our capacity for genetic toxicology and in vitro alternatives.